Skip to content

Feed Screener Search Methodology

SEC · FI · BAFIN · AFM · AMF

Pricing Sign in

InsiderLens

Statistics predict. AI explains.

Insider transactions from public regulatory disclosures, aggregated and enriched with deterministic statistical signals. Not investment advice.

Sources

SEC EDGAR · US
FINANSINSPEKTIONEN · SE
BAFIN · DE
AFM · NL
AMF · FR

Product

Methodology
Privacy notice
Object to processing

Feed Screener Search Methodology

Pricing Sign in

Hammond Matthew — Research Alliance Corp III insider: 1 transactions · InsiderLens

Home / Insiders / Hammond Matthew

Hammond Matthew

Director at Research Alliance Corp III · on record since May 19, 2026
Chief Executive Officer at Research Alliance Corp III · on record since May 19, 2026
10% owner at Research Alliance Corp III · on record since May 19, 2026
Director at Therapeutics Acquisition Corp. · on record since Jul 7, 2020
Chief Financial Officer at Therapeutics Acquisition Corp. · on record since Jul 7, 2020
Director at Research Alliance Corp. II · on record since Mar 17, 2021
Chief Investment Officer at Research Alliance Corp. II · on record since Mar 17, 2021

Insider trading activity of Hammond Matthew

Transactions on record: 1; since May 21, 2026

Open-market buys: 0

Open-market sells: 0

Companies traded: 1; last filing May 21, 2026

Figures computed from official regulatory filings — methodology.

Companies where Hammond Matthew has traded

Research Alliance Corp III1 tx · $2.8M · May 21, 2026

Track record of Hammond Matthew

Insufficient history for a statistical track record (fewer than 5 open-market buys).

Transaction history of Hammond Matthew

Co-insiders of Hammond Matthew

Kolchinsky PeterResearch Alliance Corp. II +1
Adams Francis ShermanResearch Alliance Corp III
BIOTECHNOLOGY VALUE FUND II LPTherapeutics Acquisition Corp.
BIOTECHNOLOGY VALUE FUND L PTherapeutics Acquisition Corp.
Biotechnology Value Trading Fund OS LPTherapeutics Acquisition Corp.
BVF GP HOLDINGS LLCTherapeutics Acquisition Corp.
BVF I GP LLCTherapeutics Acquisition Corp.

This page republishes public regulatory disclosures. Concerned by this data? Exercise your right to object →

BVF II GP LLCTherapeutics Acquisition Corp.

BVF INC/ILTherapeutics Acquisition Corp.

BVF PARTNERS L P/ILTherapeutics Acquisition Corp.

BVF Partners OS Ltd.Therapeutics Acquisition Corp.

Cameron TheresaResearch Alliance Corp. II

DEMERS WILLIAM L.Therapeutics Acquisition Corp.

FLESHNER NEIL E.Therapeutics Acquisition Corp.

GILMOUR MARGARET E.Therapeutics Acquisition Corp.

GOODMAN JONATHAN R.Therapeutics Acquisition Corp.

GOTTLIEB MICHAEL M.Therapeutics Acquisition Corp.

Grau DanielTherapeutics Acquisition Corp.

GRAY MICHAELTherapeutics Acquisition Corp.

HOFFMAN STEPHEN JResearch Alliance Corp. II

HOGUE GERALD L.Therapeutics Acquisition Corp.

JENSEN JESSICA D.Therapeutics Acquisition Corp.

KELLY JUSTYNATherapeutics Acquisition Corp.

LAMPERT MARK NTherapeutics Acquisition Corp.

Leggett ThomasResearch Alliance Corp. II

Lubner David CharlesTherapeutics Acquisition Corp.

MacLean Michael FResearch Alliance Corp III

Malik RajeshTherapeutics Acquisition Corp.

MARGOLIN YAELTherapeutics Acquisition Corp.

Martell Bridget ATherapeutics Acquisition Corp.

MCCANN JOE A.Therapeutics Acquisition Corp.

Miller Timothy JResearch Alliance Corp III

Patience CliveResearch Alliance Corp. II

RA Capital Biotech Fund LPTherapeutics Acquisition Corp.

RA CAPITAL MANAGEMENT, LLCTherapeutics Acquisition Corp.

Research Alliance Holdings III LLC /CaymanResearch Alliance Corp III

Research Alliance Holdings II LLCResearch Alliance Corp. II

Saba Capital Management, L.P.Research Alliance Corp. II

Shah Rajeev M.Therapeutics Acquisition Corp.

SILBER ALLAN CTherapeutics Acquisition Corp.

Stusnick Henry WilliamResearch Alliance Corp III

Therapeutics Acquisition Holdings LLCTherapeutics Acquisition Corp.

Weinstein BoazResearch Alliance Corp. II

Company	Filed	Type	Qty	Price	Value · USD	Src
Research Alliance Corp III	May 21, 2026	Award	275,000	10.00 USD	$2.8M	SEC